Diabetes UK responds to diabetes lockdown study

Diabetes UK responds to study investigating impact of lockdown on diabetes control

 The meta-analysis, presented at the Annual Meeting of the European Association for the Study of Diabetes, suggested that blood sugar control improved in people with type 1 diabetes, whereas lockdown contributed to a short-term worsening in blood sugar control in many people with type 2 diabetes.

 Nikki Joule, Policy Manager at Diabetes UK, said:

“This study offers important insights into how people living with diabetes were able to manage their condition during lockdown. While people living with type 1 diabetes had overall improved management, lockdown appears to have had a detrimental effect on diabetes management for those living with type 2 diabetes.

“Diabetes technologies can have a really positive impact on blood sugar management and wellbeing. It is crucial that everyone who might benefit from diabetes tech has access to it, and these findings among those with type 1 diabetes reiterate just how pivotal diabetes tech can be.

“It’s worrying that lockdown had a negative impact on diabetes management for those with type 2 diabetes. The backlog in routine diabetes care must urgently be addressed, so that those living with diabetes can access the support and care they need.”